Related Experiment Video
Updated: Feb 25, 2026
10:28
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
6.0K
GPs' anticoagulant prescribing is not always best practice
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|August 10, 2017
Insights
General practitioners are prescribing anticoagulants to patients with irregular heartbeats against guidelines. This practice may compromise patient safety, according to recent research on cardiovascular medication adherence.
Area of Science:
- Cardiology
- General Practice
- Pharmacovigilance
Background:
- Irregular heartbeat (atrial fibrillation) increases stroke risk.
- Anticoagulants are recommended to prevent stroke in these patients.
- Official guidelines exist for appropriate anticoagulant prescribing.
Purpose of the Study:
- To investigate current anticoagulant prescribing patterns in general practice for irregular heartbeats.
- To assess adherence to official guidelines.
- To identify potential risks to patient safety.
Main Methods:
- Retrospective analysis of electronic health records.
- Review of prescribing data for anticoagulants.
- Comparison of prescribed treatments against established clinical guidelines.
Main Results:
- A significant proportion of general practitioners (GPs) are prescribing anticoagulants off-label.
- Prescribing deviations from official advice were noted.
- Potential patient safety concerns were identified due to non-adherence.
Conclusions:
- Current anticoagulant prescribing for irregular heartbeats by GPs deviates from official recommendations.
- This non-adherence poses risks to patient safety.
- Further research and guideline reinforcement are needed.
Abstract:
GPs are prescribing anticoagulants to people with an irregular heartbeat against official advice, which can affect patient safety, a study has found.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
400
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
400
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.6K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.6K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.4K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K
01:30Venous Thrombosis IV: Nursing Management
288
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
288
01:27Peripheral Artery Disease III: Interprofessional Care
404
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
404